Compare Abbott India with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs PIRAMAL ENTERPRISES - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA PIRAMAL ENTERPRISES ABBOTT INDIA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 47.8 15.4 309.8% View Chart
P/BV x 13.7 1.0 1,396.7% View Chart
Dividend Yield % 0.5 1.8 27.9%  

Financials

 ABBOTT INDIA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
PIRAMAL ENTERPRISES
Mar-19
ABBOTT INDIA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs6,1103,303 185.0%   
Low Rs3,9961,797 222.4%   
Sales per share (Unadj.) Rs1,552.2716.5 216.6%  
Earnings per share (Unadj.) Rs188.879.7 236.9%  
Cash flow per share (Unadj.) Rs196.4107.9 182.0%  
Dividends per share (Unadj.) Rs55.0028.00 196.4%  
Dividend yield (eoy) %1.11.1 99.1%  
Book value per share (Unadj.) Rs796.61,477.5 53.9%  
Shares outstanding (eoy) m21.25184.45 11.5%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x3.33.6 91.5%   
Avg P/E ratio x26.832.0 83.7%  
P/CF ratio (eoy) x25.723.6 108.9%  
Price / Book Value ratio x6.31.7 367.6%  
Dividend payout %29.135.1 82.9%   
Avg Mkt Cap Rs m107,376470,292 22.8%   
No. of employees `0003.37.8 42.5%   
Total wages/salary Rs m3,93722,504 17.5%   
Avg. sales/employee Rs Th9,929.316,899.4 58.8%   
Avg. wages/employee Rs Th1,185.12,877.7 41.2%   
Avg. net profit/employee Rs Th1,207.71,879.9 64.2%   
INCOME DATA
Net Sales Rs m32,985132,153 25.0%  
Other income Rs m1,1703,128 37.4%   
Total revenues Rs m34,155135,281 25.2%   
Gross profit Rs m5,24566,290 7.9%  
Depreciation Rs m1625,202 3.1%   
Interest Rs m3844,097 0.1%   
Profit before tax Rs m6,21520,119 30.9%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2038,611 25.6%   
Profit after tax Rs m4,01214,701 27.3%  
Gross profit margin %15.950.2 31.7%  
Effective tax rate %35.442.8 82.8%   
Net profit margin %12.211.1 109.3%  
BALANCE SHEET DATA
Current assets Rs m22,655122,742 18.5%   
Current liabilities Rs m6,681310,810 2.1%   
Net working cap to sales %48.4-142.3 -34.0%  
Current ratio x3.40.4 858.7%  
Inventory Days Days6523 280.8%  
Debtors Days Days2939 75.1%  
Net fixed assets Rs m835116,904 0.7%   
Share capital Rs m213369 57.6%   
"Free" reserves Rs m16,715272,161 6.1%   
Net worth Rs m16,928272,530 6.2%   
Long term debt Rs m0270,196 0.0%   
Total assets Rs m24,162856,261 2.8%  
Interest coverage x163.71.5 11,240.7%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x1.40.2 884.5%   
Return on assets %16.86.9 244.1%  
Return on equity %23.75.4 439.4%  
Return on capital %36.912.4 297.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36915,200 2.4%   
Fx outflow Rs m3,8074,889 77.9%   
Net fx Rs m-3,43810,312 -33.3%   
CASH FLOW
From Operations Rs m1,527-115,975 -1.3%  
From Investments Rs m-2,148-8,265 26.0%  
From Financial Activity Rs m-1,024107,525 -1.0%  
Net Cashflow Rs m-1,646-16,650 9.9%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 4.0 197.5%  
FIIs % 0.1 26.6 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 16.5 103.6%  
Shareholders   18,270 93,274 19.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DR. DATSONS LABS  STRIDES PHARMA SCIENCE  CIPLA  FDC LTD.  VENUS REMEDIES  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Telecom and Automobiles Stocks Lose(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.1% while the Hang Seng is down 0.1%.

Related Views on News

PIRAMAL ENTERPRISES Surges by 5%; BSE HEALTHCARE Index Up 1.0% (Market Updates)

Oct 18, 2019 | Updated on Oct 18, 2019

PIRAMAL ENTERPRISES share price has surged by 5% and its current market price is Rs 1,546. The BSE HEALTHCARE is up by 1.0%. The top gainers in the BSE HEALTHCARE Index is PIRAMAL ENTERPRISES (up 5.1%). The top losers are PROCTER & GAMBLE HEALTH and DR. REDDYS LAB .

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Oct 18, 2019 11:57 AM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS